Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
11
result was found. Results that relate to
Adverse reactions
Relationship between HLA-B*1502 gene polymorphism and skin adverse reactions caused by aromatic ASMs in children with epilepsy of different nationalities in Xinjiang
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(2):151-157.
1540 times
600 times
Ting ZHAO
Hong-Jian LI
Yan SUN
Ting-Ting WANG
Jie FENG
Hui-Lan ZHANG
Hui-Dong BAI
Wei-Jiang ZHU
Yan-Ju LI
Lu-Hai YU
Epilepsy
Anti-seizure medications
Skin adverse reactions
HLA-B*1502 gene
Details
Application value of valsartan combined with Bailing capsule in the treatment of proteinuria patients with chronic nephritis
Published on
Journal of Mathematical Medicine
2023,36(3):208-214.
1992 times
664 times
Xiao-Cao LYU
Gai LYU
Ti CAO
Bing LU
Chronic nephritis
Valsartan
Bailing capsule
Proteinuria
Renal function
Adverse reactions
Details
Neurologic adverse reactions caused by varaciclovir dispersible tablets in hemodialysis patients: a case report
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(5):596-600.
1576 times
598 times
Jing CHEN
Hua CHENG
Varaciclovir
Hemodialysis
Neurologic
Adverse reactions
Details
Analysis of clinical efficacy of febuxostat combined with etoricoxib in the treatment of gouty arthritis
Published on
Journal of Mathematical Medicine
2023,36(6):446-451.
3251 times
1180 times
Ye HE
Ming-Zhi HONG
Xiao-Chun ZHU
Gouty arthritis
Febuxostat
Etoricoxib
Clinical efficacy
Adverse reactions
Details
A case of pharmaceutical caring for psychiatric abnormalities associated with low dose regorafenib in the treatment of advanced soft tissue sarcoma
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(4):466-470.
3035 times
824 times
FANG Shasha
AN Wei
TIAN Ying
YU Qianqian
ZHANG Mingwei
CHEN Min
Regorafenib
Soft tissue sarcoma
Mental disorders
Drug adverse reactions
Pharmaceutical care
Details
Rapid progression of colitis caused by lenvatinib combined with tislelizumab for hepatocellular carcinoma treatment: a case study
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):349-354.
3226 times
1698 times
MA Jinyuan
WANG Bei
ZHU Quangang
WANG Zhengxin
TAO Yifeng
QIU Xiaoyan
Tyrosine kinase inhibitor
Anti-PD-1
Immune-related adverse reactions
Immune-related colitis
Case report
Details
CiteSpace bibliometric analysis of safety and risk studies of antibody drugs in China
Published on
Frontiers in Pharmaceutical Sciences
2024,27(6):1019-1027.
2050 times
486 times
PENG Yue
LIU Lingling
CAI Yuanxuan
ZHAO Yuhang
SHANGGUAN Xiaofang
LI Kangling
CHEN Zherui
LI Ke
HUANG Rui
LU Yuanyuan
Antibody drugs
CiteSpace
Safety
Risk
Adverse reactions
Bibliometrics
Drug safety
Risk management
Details
Clinical efficacy and safety of azithromycin sequential therapy combined with risk management in the treatment of mycoplasma pneumoniae pneumonia in children
Published on
Frontiers in Pharmaceutical Sciences
2024,27(8):1353-1359.
2168 times
360 times
WANG Yongmei
GONG Min
XU Meiyan
JIANG Rong
Azithromycin
Risk management
Mycoplasma pneumoniae pneumonia
Inflammatory cytokines
Drug related adverse reactions
Nursing
Satisfaction
Details
Effect of propofol combined with etomidate on hemodynamics and stress response during weight loss surgery
Published on
Frontiers in Pharmaceutical Sciences
2024,28(2):206-212.
1873 times
245 times
JIAO Hongwei
FENG Xiaoyue
MA Peng
DUAN Yinglei
LYU Zhigan
Weight loss surgery
Propofol
Etomidate
Hemodynamics
Stress response
Cognitive impairment
Adverse reactions
Details
Literature analysis of adverse reactions to multiple organ injury induced by camrelizumab
Published on
Frontiers in Pharmaceutical Sciences
2024,28(4):648-656.
1460 times
172 times
ZHANG Yang
SU Wenyang
GAO Yue
Camrelizumab
Multiple organ injury
Adverse reactions
Literature system analysis
Immunotherapy
Programmed death protein 1
Details
A case report of ischemic bowel disease caused by Shengxuexiaoban capsules
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(2):236-240.
923 times
123 times
XU Cuilin
LI Binbin
HU Jing
HU Naizhong
WANG Yanyan
Shengxuexiaoban capsules
Ischemic bowel disease
Adverse reactions
Details